Liraglutide, a GLP-1 agonist, as a new adjunct treatment in Hailey-Hailey disease, a case report
The long-term cardiovascular safety profile of both compounds remains to be fully characterized
For many people who have struggled with losing weight, semaglutide-based diabetes drugs such as Ozempic and Wegovy have offered a different approach to weight loss
60 However, in humans, early studies demonstrated that GLP-2 administration for five weeks increased spinal BMD in people with short bowel syndrome, 62 but had limited overall bone benefits
Proteins Casein protein [129], whey proteins [130], peptones [131], and different amino acids such as l-glutamine [132], l-phenylalanine [133], L-tryptophan [134], and l-arginine induce GLP-1 secretion through activation of the calcium-sensing receptor (CaSR), the taste receptor TAS1R1/TAS1R3, G-protein-coupled receptor 6A (GPRC6A) [135], GPR142, peptide transporter-1 (PEPT1) [136], and amino acid (AA) transporter [137] (Fig